Fig. 3From: Dose coverage and breath-hold analysis of breast cancer patients treated with surface-guided radiotherapyBar graph showing D98 for a threshold of 95%, 93%, and 90% of the prescribed dose, for the breast CTV (60 patients), chest wall CTV (24 patients), axillary lymph node level 1–2 CTV (22 patients), axillary lymph node level 3–4 CTV (23 patients), axillary lymph node level 1–4 CTV (22 patients), and IMN (12 patients) CTVBack to article page